FSSAI files three cases against Nestlé India over infant nutrition claims, biotin level
India’s food regulator has initiated three adjudication cases involving promotional claims for NAN Excella Pro Stage 1 and Lactogen Pro 1, plus an alleged biotin shortfall in a follow-up formula. Nestlé India said its products and labels comply with applicable regulations.
What happened
FSSAI has filed three adjudication cases against Nestle India over promotional claims for NAN Excella Pro Stage 1 and Lactogen Pro 1, and an alleged biotin
Key facts
- 3 separate cases
- 5 HMOs
- Regulation 4(2)
- Section 3
- 2020
- 1992
Why this matters
The scrutiny increases the value of rigorous regulatory diligence for nutrition assets in India, particularly around substantiated claims, label compliance and quality-control systems.